The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction

por Valkema, M. J., Mostert, B., Lagarde, S. M., Wijnhoven, B. P. L., van Lanschot, J. J. B.
Publicado 2022

Fixed Size of Enlarged Calcified Lymph Nodes in Esophageal Adenocarcinoma despite Complete Remission

por Grotenhuis, B.A., Wijnhoven, B.P.L., Hermans, J.J., Biermann, K., van Lanschot, J.J.B.
Publicado 2009

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma

por Tuynman, J B, Lagarde, S M, ten Kate, F J W, Richel, D J, van Lanschot, J J B
Publicado 2008

Radiological evaluation of colorectal anastomoses

por Doeksen, A., Tanis, P. J., Wüst, A. F. J., Vrouenraets, B. C., van Lanschot, J. J. B., van Tets, W. F.
Publicado 2008

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado 2011

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer

por Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., van Lanschot, J. J. B.
Publicado 2010

Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature

por Collée, G. E., van der Wilk, B. J., van Lanschot, J. J. B., Busschbach, J. J., Timmermans, L., Lagarde, S. M., Kranenburg, L. W.
Publicado 2020

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

por ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Publicado 2017

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer

por de Jongh, M, Eyck, B M, van der Werf, L R, Toxopeus, E L A, van Lanschot, J J B, Lagarde, S M, van der Gaast, A, Nuyttens, J, Wijnhoven, B P L
Publicado 2021

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences

por de Boer, A G E M, Stalmeier, P F M, Sprangers, M A G, de Haes, J C J M, van Sandick, J W, Hulscher, J B F, van Lanschot, J J B
Publicado 2002

Germline variant in MSX1 identified in a Dutch family with clustering of Barrett’s esophagus and esophageal adenocarcinoma

por van Nistelrooij, A. M. J., van Marion, R., van Ijcken, W. F. J., de Klein, A., Wagner, A., Biermann, K., Spaander, M. C. W., van Lanschot, J. J. B., Dinjens, W. N. M., Wijnhoven, B. P. L.
Publicado 2017

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

por Schreurs, L. M. A., Janssens, A. C. J. W., Groen, H., Fockens, P., van Dullemen, H. M., van Berge Henegouwen, M. I., Sloof, G. W., Pruim, J., van Lanschot, J. J. B., Steyerberg, E. W., Plukker, J. Th. M.
Publicado 2011

Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer

por Noordman, B. J., Verdam, M. G. E., Onstenk, B., Heisterkamp, J., Jansen, W. J. B. M., Martijnse, I. S., Lagarde, S. M., Wijnhoven, B. P. L., Acosta, C. M. M., van der Gaast, A., Sprangers, M. A. G., van Lanschot, J. J. B.
Publicado 2019

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial

por van der Wilk, B. J., Eyck, B. M., Doukas, M., Spaander, M. C. W., Schoon, E. J., Krishnadath, K. K., Oostenbrug, L. E., Lagarde, S. M., Wijnhoven, B. P. L., Looijenga, L. H. J., Biermann, K., van Lanschot, J. J. B.
Publicado 2020

Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study

por Markar, S. R., Noordman, B. J., Mackenzie, H., Findlay, J. M., Boshier, P. R., Ni, M., Steyerberg, E. W., van der Gaast, A., Hulshof, M. C. C. M., Maynard, N., van Berge Henegouwen, M. I., Wijnhoven, B. P. L., Reynolds, J. V., Van Lanschot, J. J. B., Hanna, G. B.
Publicado 2017

Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process

por Konradsson, M, van Berge Henegouwen, M I, Bruns, C, Chaudry, M A, Cheong, E, Cuesta, M A, Darling, G E, Gisbertz, S S, Griffin, S M, Gutschow, C A, van Hillegersberg, R, Hofstetter, W, Hölscher, A H, Kitagawa, Y, van Lanschot, J J B, Lindblad, M, Ferri, L E, Low, D E, Luyer, M D P, Ndegwa, N, Mercer, S, Moorthy, K, Morse, C R, Nafteux, P, Nieuwehuijzen, G A P, Pattyn, P, Rosman, C, Ruurda, J P, Räsänen, J, Schneider, P M, Schröder, W, Sgromo, B, Van Veer, H, Wijnhoven, B P L, Nilsson, M
Publicado 2019

Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)

por Brenkman, H. J. F., Gertsen, E. C., Vegt, E., van Hillegersberg, R., van Berge Henegouwen, M. I., Gisbertz, S. S., Luyer, M. D. P., Nieuwenhuijzen, G. A. P., van Lanschot, J. J. B., Lagarde, S. M., de Steur, W. O., Hartgrink, H. H., Stoot, J. H. M. B., Hulsewe, K. W. E., Spillenaar Bilgen, E. J., van Det, M. J., Kouwenhoven, E. A., van der Peet, D. L., Daams, F., van Sandick, J. W., van Grieken, N. C. T., Heisterkamp, J., van Etten, B., Haveman, J. W., Pierie, J. P., Jonker, F., Thijssen, A. Y., Belt, E. J. T., van Duijvendijk, P., Wassenaar, E., van Laarhoven, H. W. M., Wessels, F. J., Haj Mohammad, N., van Stel, H. F., Frederix, G. W. J., Siersema, P. D., Ruurda, J. P.
Publicado 2018